Innovative Eyewear, Inc. (LUCY)
USD 5.55
(-7.65%)
USD 5.55
(-7.65%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -6.9 Million USD | -22.93% |
| 2022 | -5.57 Million USD | -73.99% |
| 2021 | -3.2 Million USD | -392.41% |
| 2020 | -650.88 Thousand USD | -494.82% |
| 2019 | -109.42 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.97 Million USD | 100.0% |
| 2024 Q1 | -657 Thousand USD | 73.67% |
| 2023 Q4 | -2.49 Million USD | -405.17% |
| 2023 FY | -6.85 Million USD | -22.93% |
| 2023 Q3 | -493.99 Thousand USD | 54.76% |
| 2023 Q2 | -1.09 Million USD | 23.58% |
| 2023 Q1 | -1.42 Million USD | 23.72% |
| 2022 Q2 | -1.14 Million USD | 3.39% |
| 2022 Q1 | -1.18 Million USD | 13.84% |
| 2022 FY | -5.57 Million USD | -73.99% |
| 2022 Q4 | -1.87 Million USD | -37.08% |
| 2022 Q3 | -1.36 Million USD | -18.98% |
| 2021 Q1 | -216.35 Thousand USD | -3.41% |
| 2021 FY | -3.2 Million USD | -392.41% |
| 2021 Q2 | -517.8 Thousand USD | -139.33% |
| 2021 Q4 | -1.37 Million USD | -26.42% |
| 2021 Q3 | -1.09 Million USD | -110.75% |
| 2020 Q2 | -136.63 Thousand USD | 0.0% |
| 2020 FY | -650.88 Thousand USD | -494.82% |
| 2020 Q4 | -209.22 Thousand USD | -22.7% |
| 2020 Q3 | -170.52 Thousand USD | -24.8% |
| 2020 Q1 | -136.63 Thousand USD | 0.0% |
| 2019 FY | -109.42 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 88.034% |
| AngioDynamics, Inc. | -97.71 Million USD | 92.938% |
| AtriCure, Inc. | -26.68 Million USD | 74.139% |
| Avinger, Inc. | -16.63 Million USD | 58.518% |
| Azenta, Inc. | -73.12 Million USD | 90.563% |
| BioLife Solutions, Inc. | -70.82 Million USD | 90.257% |
| The Cooper Companies, Inc. | 533.1 Million USD | 101.294% |
| Daxor Corporation | -177.07 Thousand USD | -3796.96% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 54.337% |
| Femasys Inc. | -14.5 Million USD | 52.438% |
| GlucoTrack, Inc. | -7.1 Million USD | 2.864% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 464.337% |
| Hologic, Inc. | 882.6 Million USD | 100.782% |
| ICU Medical, Inc. | 22.82 Million USD | 130.232% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 100.391% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 32.809% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 118.609% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -0.0% |
| Masimo Corporation | 136.5 Million USD | 105.055% |
| Microbot Medical Inc. | -9.85 Million USD | 29.979% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 147.023% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 105.567% |
| Nephros, Inc. | -1.59 Million USD | -333.179% |
| NovoCure Limited | -232.87 Million USD | 97.037% |
| NEXGEL, Inc. | -3.47 Million USD | -98.463% |
| NEXGEL, Inc. | -3.47 Million USD | -98.463% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 93.287% |
| OraSure Technologies, Inc. | 54.07 Million USD | 112.76% |
| Pro-Dex, Inc. | 7.17 Million USD | 196.202% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 84.164% |
| Predictive Oncology Inc. | -13.92 Million USD | 50.432% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -153.293% |
| QuidelOrtho Corporation | 139.1 Million USD | 104.961% |
| Repligen Corporation | 54.57 Million USD | 112.644% |
| Sanara MedTech Inc. | -4.21 Million USD | -63.708% |
| STAAR Surgical Company | 28.09 Million USD | 124.56% |
| Sharps Technology, Inc. | -10.12 Million USD | 31.858% |
| Utah Medical Products, Inc. | 16.77 Million USD | 141.131% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 91.882% |
| Jin Medical International Ltd. | 2.86 Million USD | 340.667% |